Successful exit: Miltenyi Biotec acquires biosensor company lino Biotech

21-Mar-2023 - lino Biotech, a biosensor company and the world’s only provider of Focal Molography®, announced it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023. Since its founding in 2020, lino Biotech has made significant advances in developing new ...

Miltenyi Biotec acquires microscopy specialist

18-Oct-2018 - Miltenyi Biotec GmbH announced that it has acquired the high-end microscopy specialist LaVision BioTec GmbH. Located in Bielefeld, Germany, LaVision BioTec is a leading global specialist for advanced light-sheet and multiphoton microscopy solutions for life science applications. Since its ...

Cancer-fighting gene therapy

Technology transfer project at the MDC

12-May-2016 - The Max Delbrück Center for Molecular Medicine (MDC), part of the Helmholtz Association, has announced a cooperation project between two MDC research groups and three industry partners: the ‘Max Delbrück Center Cell Engineering Lab’ (MD-CEL). Their joint goal is to develop a cell-based gene ...

Miltenyi Biotec acquires gene therapy assets from Lentigen Corporation

18-Aug-2014 - Miltenyi Biotec announced that it has acquired the lentiviral vector manufacturing business and related assets from US company Lentigen Corporation, a global leader in lentiviral technology for cell and gene therapy applications. The acquisition further strengthens Miltenyi Biotec’s portfolio in ...

Miltenyi Biotec GmbH Acquires Medic Tools AG

12-Jun-2008 - Miltenyi Biotec has acquired Medic Tools AG from Zug, Switzerland. With this acquisition, Miltenyi Biotec strengthens the portfolio in the area of sample preparation. "The innovative and high-quality devices and techniques fit perfectly into the product range of instruments, reagents, and ...

Miltenyi Biorec becomes Agilent Technologies certified Microarray Service Provider

01-Mar-2005 - Miltenyi Biotec GmbH announced its certification under the Agilent Technologies Certified Microarray Service Provider Program. Memorec Biotec, a subsidiary of Miltenyi Biotech focused on high-throughput gene expression profiling, has also become certified. The certification validates the ...

Miltenyi Biotec Strengthens Its Global Presence

07-Feb-2005 - Miltenyi Biotec announced that it is setting up its Asia Pacific headquarters in Singapore, which will manage the company's regional operations in South East Asia, Japan, China, Hong Kong, Korea, Taiwan and Australia. Miltenyi Biotec is the world leader in magnetic cell separation and has a ...

Miltenyi Biotec Sets up International Headquarters in Singapore

The world's no.1 in magnetic cell separation and cellular therapy strengthens its presence in the Asia-Pacific Rim.

16-Dec-2004 - Singapore. Singapore is the dynamic gate to Asia, and in recognition of this fact, Miltenyi Biotec has opened the international headquarters at Suntec City. During the initial phase of operation, this has already led to the foundation of subsidiaries in Japan (Tokyo), China (Shanghai, Beijing), ...

Baxter and Miltenyi Biotec Sign 5-Year Distribution Agreement for Cellular Therapy Products

01-Oct-2003 - Baxter Healthcare Corporation and Miltenyi Biotec GmbH announced today that they have signed an agreement whereby Miltenyi Biotec will have exclusive rights for five years to distribute, market and sell Baxter's cellular therapy products worldwide, with the exception of China, Japan, Korea and ...